Is risk of central nervous system (CNS) relapse related to adjuvant taxane treatment in node-positive breast cancer? Results of the CNS substudy in the intergroup phase III BIG 02-98 trial

BC Pestalozzi; P Francis; E Quinaux; S Dolci; E Azambuja; RD Gelber; G Viale; A Balil; M Andersson; B Nordenskjoeld; M Gnant; J Gutierrez; I Lang; JPA Crown; M Piccart-Gebhart

Journal article

Is risk of central nervous system (CNS) relapse related to adjuvant taxane treatment in node-positive breast cancer? Results of the CNS substudy in the intergroup phase III BIG 02-98 trial

BC Pestalozzi, P Francis, E Quinaux, S Dolci, E Azambuja, RD Gelber, G Viale, A Balil, M Andersson, B Nordenskjoeld, M Gnant, J Gutierrez, I Lang, JPA Crown, M Piccart-Gebhart

ANNALS OF ONCOLOGY | OXFORD UNIV PRESS | Published : 2008

DOI: 10.1093/annonc/mdn385

University of Melbourne Researchers

Prudence Francis Author Medicine - St Vincent's Hospital

Grants

Awarded by National Health and Medical Research Council

Awarded by U. S. NCI

Funding Acknowledgements

Australian New Zealand Breast Cancer Trials Group from National Health and Medical Research Council (100925 and 351164); U. S. NCI (CA-73362) to RDG; Swiss Group for Clinical Cancer Research.